These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 17689752

  • 21. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
    Morabito N, Russo GT, Gaudio A, Lasco A, Catalano A, Morini E, Franchina F, Maisano D, La Rosa M, Plota M, Crifò A, Meo A, Frisina N.
    Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
    [Abstract] [Full Text] [Related]

  • 22. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women.
    Prezelj J, Ostanek B, Logar DB, Marc J, Hawa G, Kocjan T.
    Menopause; 2008 Jun; 15(2):369-73. PubMed ID: 17882010
    [Abstract] [Full Text] [Related]

  • 23. Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?
    Spelling P, Bonfá E, Caparbo VF, Pereira RM.
    Scand J Rheumatol; 2008 Jun; 37(6):439-44. PubMed ID: 18802807
    [Abstract] [Full Text] [Related]

  • 24. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major.
    Angelopoulos NG, Goula A, Katounda E, Rombopoulos G, Kaltzidou V, Kaltsas D, Konstandelou E, Tolis G.
    Pediatr Hematol Oncol; 2007 Jun; 24(7):481-91. PubMed ID: 17786784
    [Abstract] [Full Text] [Related]

  • 25. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D, Thongchote K, Charoenphandhu N, Pandaranandaka J, Tudpor K, Teerapornpuntakit J, Suthiphongchai T, Krishnamra N.
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [Abstract] [Full Text] [Related]

  • 26. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
    Paker N, Bugdayci D, Tekdos D, Dere C, Kaya B.
    J Stroke Cerebrovasc Dis; 2009 Mar; 18(2):139-43. PubMed ID: 19251190
    [Abstract] [Full Text] [Related]

  • 27. The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.
    Stern A, Laughlin GA, Bergstrom J, Barrett-Connor E.
    Eur J Endocrinol; 2007 May; 156(5):555-62. PubMed ID: 17468191
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis.
    Jabbar S, Drury J, Fordham JN, Datta HK, Francis RM, Tuck SP.
    J Clin Pathol; 2011 Apr; 64(4):354-7. PubMed ID: 21307155
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Raloxifene therapy interacts with serum osteoprotegerin in postmenopausal women.
    Messalli EM, Mainini G, Scaffa C, Cafiero A, Salzillo PL, Ragucci A, Cobellis L.
    Maturitas; 2007 Jan 20; 56(1):38-44. PubMed ID: 16787719
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men.
    Gibellini D, Borderi M, De Crignis E, Cicola R, Vescini F, Caudarella R, Chiodo F, Re MC.
    J Med Virol; 2007 Oct 20; 79(10):1446-54. PubMed ID: 17705184
    [Abstract] [Full Text] [Related]

  • 36. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P.
    Neuro Endocrinol Lett; 2007 Oct 20; 28(5):621-8. PubMed ID: 17984937
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
    García-Unzueta MT, Riancho JA, Zarrabeitia MT, Sañudo C, Berja A, Valero C, Pesquera C, Paule B, González-Macías J, Amado JA.
    Horm Metab Res; 2008 Mar 20; 40(3):219-24. PubMed ID: 18348083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.